| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9224242 | Annales de Dermatologie et de Vénéréologie | 2005 | 6 Pages |
Abstract
In the light of this study, many supplementary treatments with topical corticosteroids during AD do not resist “evidence-based” clinical trials. However, the individual benefits of some of these treatments should not be ruled out.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
P. Plantin,